Back to News
Market Impact: 0.25

Noteworthy Wednesday Option Activity: AAP, ZVRA, TJX

ZVRATJXAAPDSVIGNDAQ
Futures & OptionsDerivatives & VolatilityMarket Technicals & Flows
Noteworthy Wednesday Option Activity: AAP, ZVRA, TJX

Zevra Therapeutics (ZVRA) and TJX Companies (TJX) are experiencing notably high options trading volume today, with ZVRA's volume at 63.3% and TJX's at 62.5% of their respective average daily share trading volumes. This activity is concentrated in specific call options, including ZVRA's $10 strike expiring November 2025 and TJX's $125 strike expiring August 2025, suggesting increased speculative or hedging interest around these price points and future dates.

Analysis

Zevra Therapeutics (ZVRA) and TJX Companies (TJX) are experiencing significant options market activity, with today's contract volumes representing a substantial portion of their respective average daily share volumes. Specifically, ZVRA's options volume equates to 63.3% of its 1.0 million share average, while TJX's activity accounts for 62.5% of its 4.7 million share average. This heightened interest is not diffuse but concentrated in specific long-dated call options. For ZVRA, a notable 1,678 contracts were traded for the $10 strike call expiring in November 2025. For TJX, the activity is even more pronounced, with 8,690 contracts traded for the $125 strike call expiring in August 2025. This pattern of high-volume, long-dated call buying suggests that certain market participants are making significant bullish speculations or establishing strategic hedges related to substantial future price appreciation for both companies.

AllMind AI Terminal

AI-powered research, real-time alerts, and portfolio analytics for institutional investors.

Request a Demo

Market Sentiment

Overall Sentiment

neutral

Sentiment Score

0.00

Ticker Sentiment

AAP0.00
DSV0.00
IG0.00
NDAQ0.00
TJX0.00
ZVRA0.00

Key Decisions for Investors

  • The unusual options volume in ZVRA and TJX warrants close monitoring, as such concentrated activity can be a leading indicator of future stock price volatility or the anticipation of a significant catalyst.
  • For Zevra Therapeutics, the heavy trading in November 2025 $10 calls may signal a bullish long-term outlook, prompting an evaluation of the company's pipeline and growth prospects relative to this strike price.